To confirm the effect of the previously identified PD GWAS loci in LRRK2, we first verified the associations of the known pathogenic variant p.G2019S (OR: 9.02, 95% CI: 6.14–13.25, P = 3.66E‐29) and the 5′ noncoding variant rs76904798 (OR: 1.12, 95% CI: 1.08–1.16, P = 4.01E‐09) in a meta‐analysis of all 15 data sets (Table 2; Fig. S7). The gene discussed is LRRK2; the disease is Parkinson disease.